Literature DB >> 28376409

Cognitive training to improve memory in individuals undergoing electroconvulsive therapy: Negative findings.

Jimmy Choi1, Yuanjia Wang2, Tianshu Feng3, Joan Prudic4.   

Abstract

Although electroconvulsive therapy (ECT) remains the most effective treatment for severe depression, some patients report persistent memory problems following ECT that impact their quality of life and their willingness to consent to further ECT. While cognitive training has been shown to improve memory performance in various conditions, this approach has never been applied to help patients regain their memory after ECT. In a double-blind study, we tested the efficacy of a new cognitive training program called Memory Training for ECT (Mem-ECT), specifically designed to target anterograde and retrograde memory that can be compromised following ECT. Fifty-nine patients with treatment-resistant depression scheduled to undergo ultra-brief right unilateral ECT were randomly assigned to either: (a) Mem-ECT, (b) active control comprised of nonspecific mental stimulation, or (c) treatment as usual. Participants were evaluated within one week prior to the start of ECT and then again within 2 weeks following the last ECT session. All three groups improved in global function, quality of life, depression, and self-reported memory abilities without significant group differences. While there was a decline in verbal delayed recall and mental status, there was no decline in general retrograde memory or autobiographical memory in any of the groups, with no significant memory or clinical benefit for the Mem-ECT or active control conditions compared to treatment as usual. While we report negative findings, these results continue to promote the much needed discussion on developing effective strategies to minimize the adverse memory side effects of ECT, in hopes it will make ECT a better and more easily tolerated treatment for patients with severe depression who need this therapeutic option.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive training; Depression; Electroconvulsive therapy; Memory

Mesh:

Year:  2017        PMID: 28376409      PMCID: PMC5827964          DOI: 10.1016/j.jpsychires.2017.03.016

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  38 in total

Review 1.  Electroconvulsive therapy for depression.

Authors:  Sarah H Lisanby
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Autobiographical memory and electroconvulsive therapy: do not throw out the baby.

Authors:  Harold A Sackeim
Journal:  J ECT       Date:  2014-09       Impact factor: 3.635

Review 4.  Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy.

Authors:  Jimmy Choi; Elizabeth W Twamley
Journal:  Neuropsychol Rev       Date:  2013-02-12       Impact factor: 7.444

5.  Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.

Authors:  Charles H Kellner; Mustafa M Husain; Rebecca G Knapp; W Vaughn McCall; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shirlene Sampson; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Peter B Rosenquist; Ahmad Raza; Styliani Kaliora; Vassilios Latoussakis; Kristen G Tobias; Mimi C Briggs; Lauren S Liebman; Emma T Geduldig; Abeba A Teklehaimanot; Sarah H Lisanby
Journal:  Am J Psychiatry       Date:  2016-07-15       Impact factor: 18.112

6.  The cognitive effects of electroconvulsive therapy in community settings.

Authors:  Harold A Sackeim; Joan Prudic; Rice Fuller; John Keilp; Philip W Lavori; Mark Olfson
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

7.  A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.

Authors:  H A Sackeim; J Prudic; D P Devanand; M S Nobler; S H Lisanby; S Peyser; L Fitzsimons; B J Moody; J Clark
Journal:  Arch Gen Psychiatry       Date:  2000-05

8.  Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT.

Authors:  W Vaughn McCall; David Reboussin; Joan Prudic; Roger F Haskett; Keith Isenberg; Mark Olfson; Peter B Rosenquist; Harold A Sackeim
Journal:  J Affect Disord       Date:  2012-11-15       Impact factor: 4.839

9.  Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.

Authors:  Harold A Sackeim; Joan Prudic; Mitchell S Nobler; Linda Fitzsimons; Sarah H Lisanby; Nancy Payne; Robert M Berman; Eva-Lotta Brakemeier; Tarique Perera; D P Devanand
Journal:  Brain Stimul       Date:  2008-04       Impact factor: 8.955

10.  A structured interview guide for the Hamilton Depression Rating Scale.

Authors:  J B Williams
Journal:  Arch Gen Psychiatry       Date:  1988-08
View more
  3 in total

1.  Cognitive Remediation for Schizophrenia.

Authors:  Anthony O Ahmed
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 2.  A Systematic Review and Meta-Analysis of Cognitive Training in Adults with Major Depressive Disorder.

Authors:  C Woolf; A Lampit; Z Shahnawaz; J Sabates; L M Norrie; D Burke; S L Naismith; L Mowszowski
Journal:  Neuropsychol Rev       Date:  2021-04-28       Impact factor: 7.444

3.  Cognitive remediation following electroconvulsive therapy in patients with treatment resistant depression: randomized controlled trail of an intervention for relapse prevention - study protocol.

Authors:  Nele Van de Velde; Mitchel Kappen; Ernst H W Koster; Kristof Hoorelbeke; Hannelore Tandt; Pieter Verslype; Chris Baeken; Rudi De Raedt; Gilbert Lemmens; Marie-Anne Vanderhasselt
Journal:  BMC Psychiatry       Date:  2020-09-16       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.